Common Contracts

EX-10.1 2 dex101.htm AMENDMENT NO. 1 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT AMENDMENT NO. 1 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT

Collaborative Research and License Agreement • May 5th, 2020

• Contract Type
  Collaborative Research and License Agreement
• Filed
  May 5th, 2020

This Amendment No. 1 to Collaborative Research and License Agreement (this “Amendment”), dated November 10, 2006, amends the Collaborative Research and License Agreement entered into as of December 27, 2005 (the “Agreement”) by and between AstraZeneca AB, a company limited by shares organized and existing under the laws of Sweden (“AstraZeneca”), and Targacept, Inc., a Delaware (USA) corporation (“Targacept”).

AMENDMENT NO. 1 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT

Collaborative Research and License Agreement • November 13th, 2006 • Targacept Inc • Pharmaceutical preparations

• Contract Type
  Collaborative Research and License Agreement
• Filed
  November 13th, 2006
• Company
  Targacept Inc
• Industry
  Pharmaceutical preparations

This Amendment No. 1 to Collaborative Research and License Agreement (this “Amendment”), dated November 10, 2006, amends the Collaborative Research and License Agreement entered into as of December 27, 2005 (the “Agreement”) by and between AstraZeneca AB, a company limited by shares organized and existing under the laws of Sweden (“AstraZeneca”), and Targacept, Inc., a Delaware (USA) corporation (“Targacept”).